Packaging Error Of Birth Control Pill, Mibelas, Prompts Lupin Pharmaceuticals To Recall


A packaging error of the birth control pill, Mibelas 24 Fe, prompted Lupin Pharmaceuticals to voluntarily recall them. The packaging error put placebo pills at the beginning instead of at the end of the pack.

The Packaging Error

Lupin Pharmaceuticals has voluntarily recalled its birth control pills called Mibelas 24 Fe, due to an error in packaging that put placebo pills at the beginning instead of at the end of the pack. Because of this error, women who used the pills in the given order may be pregnant, which could be a serious problem for many customers.

A professor from Northwestern University, Lauren Streicher, said that the risk of pregnancy “is very real” regarding these pills. “If you take these first four pills thinking that they are the real thing, you may be off the pill for eight days instead of four and that increases the likelihood of inadvertent pregnancy.” she said.

She pointed out that those who are mid-cycle on these pills but have not had sex, then there is no increased risk of pregnancy. However, she recommended a backup contraceptive such as condoms. Those who started the “out-of-sequence” pills and did have sex are at extreme risk. Her advice for those is: “Pray. And continue to take the rest of the pack and use back-up contraception for the remainder of the cycle, such as condoms. If they don’t get their period when they finish the pack, do a pregnancy test.”

The FDA’s Comments On the Problem

The FDA made a public warning: “For patients in whom a pregnancy is contraindicated or in whom concomitant medications may have teratogenic effects, an unintended pregnancy may cause significant adverse maternal or fetal health consequences, including death.”

They continued to say: “Consumers with questions regarding this recall can contact Lupin by phone 1-800-399-2561, 8:00 am to 5:00 pm EST, Monday through Friday.”